<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01502254</url>
  </required_header>
  <id_info>
    <org_study_id>QuIC-3</org_study_id>
    <nct_id>NCT01502254</nct_id>
  </id_info>
  <brief_title>Patients' Knowledge and Understanding of Cancer Clinical Trials - a Study of Audio Recorded Information</brief_title>
  <official_title>Patients' Knowledge and Understanding of Cancer Clinical Trials - a Randomised Study of Audio Recorded Information</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Karolinska University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Karolinska University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to test if cancer patients who are informed about, and offered
      participation in a cancer clinical trial, are more knowledgeable about cancer clinical trials
      if they have access to an audio recording of their information visit.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>October 2008</start_date>
  <completion_date type="Actual">January 2013</completion_date>
  <primary_completion_date type="Actual">January 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Patients' knowledge about clinical trials measured by the questionnaire Quality of Informed Consent</measure>
    <time_frame>The questionnaire is sent to patients within a week after consenting to the trial.</time_frame>
    <description>The questionnaire is sent to patients within a week after consenting to the trial. One reminder is sent to those not responding within two weeks.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Patients' perceived understanding of clinical trials measured by the questionnaire Quality of Informed Consent</measure>
    <time_frame>The questionnaire is sent to patients within a week after consenting to the trial.</time_frame>
    <description>The questionnaire is sent to patients within a week after consenting to the trial. One reminder is sent to those not responding within two weeks.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">130</enrollment>
  <condition>Cancer</condition>
  <arm_group>
    <arm_group_label>Copy of audio recording</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients receive a copy of the audio recorded information about the clinical trial directly after the clinical visit. This makes it possible to repeat the information before a decision is made to participate in the clinical trial or not.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>No copy of audio recording</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Patients in the control arm receive no copy of the audio recording.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>audio recorded information</intervention_name>
    <description>Access to the audio recorded information about the clinical trial the patient was information about and asked to consider. A copy of the audio recording is given to the patients directly after the clinical visit.</description>
    <arm_group_label>Copy of audio recording</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Informed in Swedish about a phase II or III clinical trial

          -  Signed a consent form
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mia Bergenmar, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Oncology, Karolinska University Hospital and Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Department of Oncology, Karolinska University Hospital</name>
      <address>
        <city>Stockholm</city>
        <zip>17176</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Sweden</country>
  </location_countries>
  <reference>
    <citation>Bergenmar M, Molin C, Wilking N, Brandberg Y. Knowledge and understanding among cancer patients consenting to participate in clinical trials. Eur J Cancer. 2008 Nov;44(17):2627-33. doi: 10.1016/j.ejca.2008.08.013. Epub 2008 Sep 23.</citation>
    <PMID>18818068</PMID>
  </reference>
  <reference>
    <citation>Bergenmar M, Johansson H, Wilking N. Levels of knowledge and perceived understanding among participants in cancer clinical trials - factors related to the informed consent procedure. Clin Trials. 2011 Feb;8(1):77-84. doi: 10.1177/1740774510384516. Epub 2010 Nov 25.</citation>
    <PMID>21109583</PMID>
  </reference>
  <verification_date>February 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 22, 2011</study_first_submitted>
  <study_first_submitted_qc>December 29, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 30, 2011</study_first_posted>
  <last_update_submitted>February 11, 2014</last_update_submitted>
  <last_update_submitted_qc>February 11, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 12, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Karolinska University Hospital</investigator_affiliation>
    <investigator_full_name>Mia Bergenmar</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Informed consent</keyword>
  <keyword>Cancer clinical trials</keyword>
  <keyword>Patient information</keyword>
  <keyword>Knowledge</keyword>
  <keyword>Questionnaire</keyword>
  <keyword>Patient Eligible for a Phase II or III Cancer Clinical Trial</keyword>
  <keyword>Scheduled Clinical Visit for Information About a Trial</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

